Author

Y Itoh

Observed names: Y ITOH, Y. Itoh

Observed institutions: Okayama University, Tokyo Metropolitan Institute of Gerontology, Nishio Municipal Hospital, Nagoya University

OpenAlex ID: A5111737595

Induction of endogenous retroviral gene product (SU) as an acute-phase protein by IL-6 in murine hepatocytes

1992 · Y ITOH, N MARUYAMA, et al. · Clinical & Experimental Immunology · 9

Murine leukaemia virus gene product as an acute phase protein: complete suppression of serum gp70 synthesis in hepatocytes of B10.S mice.

1989 · K Shigemoto, N Maruyama, et al. · PubMed · 2

PO-1291 Can we safely lower the RT dose with the use of high dose PF for advanced cervical cancer?

2021 · M. Kawamura, R. Nakahara, et al. · Radiotherapy and Oncology · 1

Clinical Results of T1 Glottic Cancer Treated with Radiotherapy Using 2.25 Gy per Fractions: A Multicenter Survey in Clinical Practice

2019 · Y. Oie, Y. Itoh, et al. · International Journal of Radiation Oncology*Biology*Physics

Investigation on Invasive or Metastatic Potentials of Human Cancer Cells as a predictive assay for long term survival after radiotherapy (RT).

1997 · Shigekazu Nakatsugawa, T. Okuda, et al. · Journal of Radiation Research

Elongation of survival period of KSN mice bearing metastatic human uterine cervical cancer by TJ-48(Juzen-Taiho-to), a Japanese herbal. after radiotherapy. : Elongation of survival period of KSN mice bearing metastatic human uterine cervical cancer by TJ-48(Juzen-Taiho-to), a Japanese herbal. after radiotherapy.

1996 · Shigekazo Nakatsugawa, T. Okuda, et al. · Journal of Radiation Research

Works count: 6

Citation count: 12

H-index: 2

I10-index: